Unitech International (BSE 531867)₹3.45+1.47%Specialty Chemicals
At the end of the Mar 2025 quarter, Unitech International's shareholders were: promoters 31.01%, public 68.99%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 5,699 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% | 31.01% |
| Public | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% | 68.99% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 3,784 | 3,748 | 3,753 | 3,707 | 3,696 | 3,775 | 4,256 | 4,879 | 5,025 | 5,234 | 5,564 | 5,699 |
| Holder | Category | Mar 2025 | Change (pp) |
|---|---|---|---|
| Desai Dhruv Rajesh | Promoter | 24.03% | 0.00 |
| Harshil Mayurbhai Shah | Public | 4.60% | −0.03 |
| Darshana Hiren Desai | Promoter | 3.94% | 0.00 |
| Daksha Rajesh Desai | Promoter | 2.96% | 0.00 |
| Ratanben Popatlal Patel | Public | 2.88% | 0.00 |
| Devang Satish Mehta | Public | 2.16% | 0.00 |
| Mukesh Patadia | Public | 1.72% | 0.00 |
| Shaniraj Rajendra Dhole | Public | 1.48% | 0.00 |
| Mayur Manubhai Shah | Public | 1.27% | 0.00 |
| Kirti Desai | Public | 1.23% | 0.00 |
| Hemil Mayurbhai Shah | Public | 1.20% | 0.00 |
| Mayurbhai Manubhai Shah Huf | Public | 1.05% | 0.00 |
| Bhikhubhai N Padsala | Public | 1.03% | 0.00 |
Promoters held 31.01% of Unitech International at the end of the Mar 2025 quarter, the same as a year earlier.
No. The Mar 2025 filing shows no pledged promoter shares.
Unitech International had 5,699 shareholders at the end of the Mar 2025 quarter, against 4,879 a year earlier.
Harshil Mayurbhai Shah (Public) held 4.60% at the end of the Mar 2025 quarter, the largest named holding outside the promoter group.